UnitedHealth Stock News

Hims & Hers (HIMS -3.91%) and UnitedHealth (UNH 4.46%) suffered huge stock price decreases that attracted investors looking to buy the dip.

The threat of tariffs and trade wars sank many stocks back in April, but the market managed a sharp turnaround since then, reminiscent of the brief pandemic crash five years earlier. Many stocks are now trading near their all-time highs, and so is the S&P 500, which is up around 5.5% through the first six months of the year.

UnitedHealth Group operates through UnitedHealthcare (insurance) and Optum (health services, tech, pharmacy), making it a global healthcare leader. Shares have plummeted over 40% in 2025, reflecting negative sentiment and recent underperformance. Q1 earnings were mixed: some growth areas, but also notable shortfalls and missed targets.

UnitedHealth Group Inc (NYSE: UNH) – the largest US health insurer – is trading at a historically attractive valuation at the time of writing. Despite the apparent bargain, however, famed investor Jim Cramer is urging caution in loading up on UNH shares.

Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benefit that comes with the discount/premium dynamic inherent in the structure. We are looking at two names today that present investors with attractive distributions and that are looking like decently ...

When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments, including Mounjaro, Zepbound, Ozempic, and Wegovy. While these drugs are likely to lead to billions in revenue, Lilly and Novo aren't relying solely on these drugs to grow their businesses.

Shares are in a big battle between bulls and bears in a consolidation zone of $300-$310. Recent Supreme Court and regulatory decisions reduce administrative burdens, benefiting insurers and potentially improving patient outcomes, which supports a positive outlook.

UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo.